Dohj LLC Purchases 60 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Dohj LLC raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,633 shares of the company’s stock after acquiring an additional 60 shares during the quarter. Dohj LLC’s holdings in HCA Healthcare were worth $790,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in HCA. Legacy Investment Solutions LLC acquired a new position in shares of HCA Healthcare during the 3rd quarter worth about $39,000. Capital Performance Advisors LLP acquired a new position in shares of HCA Healthcare during the 3rd quarter worth approximately $41,000. Canoe Financial LP acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at approximately $41,000. Northwest Investment Counselors LLC bought a new stake in HCA Healthcare during the third quarter worth $44,000. Finally, Friedenthal Financial bought a new position in shares of HCA Healthcare in the 3rd quarter valued at about $50,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $330.24 on Friday. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The firm has a market cap of $83.65 billion, a P/E ratio of 15.03, a P/E/G ratio of 1.12 and a beta of 1.64. The company’s 50-day moving average price is $313.33 and its two-hundred day moving average price is $353.05. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business posted $5.90 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.91 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. HCA Healthcare’s dividend payout ratio is 12.02%.

Insider Buying and Selling

In related news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on HCA shares. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. KeyCorp decreased their price objective on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Finally, Oppenheimer raised their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.